This VAB™ variant was developed in 2019 for the Dr. Peter Forsyth Lab at the H. Lee Moffitt Cancer Center & Research Institute.
It is designed to be mounted on the mouse skull with a 3.3mm 25ga MRI-compatible nitinol tube that accesses the cisterna magna.
To access the port, use a syringe with a PNP3M injector.
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease, Vincent Law et al, J Vis Exp. 2021 Jan 29.